6. Références bibliographiques.
1. Miller BE, Mochizuki T, Levy JH, Bailey JM, Tosone SR, Tam VK, Kanter KR. Predicting and treating coagulopathies after cardiopulmonary bypass in children. Anesth Analg 1997;85:1196-202.
2. Vivacqua A, Koch CG, Yousuf AM, Nowicki ER, Houghtaling PL, Blackstone EH, Sabik JF, 3rd. Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg 2011;91:1780-90.
3. Jakobsen CJ, Ryhammer PK, Tang M, Andreasen JJ, Mortensen PE.
Transfusion of blood during cardiac surgery is associated with higher long- term mortality in low-risk patients. Eur J Cardiothorac Surg 2012;42:114-20.
4. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA, Ghannam M, Yeo E, Djaiani G, Karski J. The independent association of massive blood loss with mortality in cardiac surgery.
Transfusion 2004;44:1453-62.
5. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
6. Edmunds LH, Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66:S12-6
7. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 1999;91:1122-51.
8. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, Darzi AW, Athanasiou T. The inflammatory response to cardiopulmonary bypass: part 1-- mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009;23:223-31.
9. Bull MH, Huse WM, Bull BS. Evaluation of tests used to monitor heparin therapy during extracorporeal circulation. Anesthesiology 1975;43:346-53.
10. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive care medicine 2004;30:1873-81.
11. McLaughlin KE, Dunning J. In patients post cardiac surgery do high doses of protamine cause increased bleeding? Interact Cardiovasc Thorac Surg 2003;2:424-6.
12. Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 1998;87:781-5.
13. Faraoni D. Editorial: management of perioperative systemic inflammation during cardiopulmonary bypass: we need a multimodal approach. Recent Pat Cardiovasc Drug Discov 2012;7:163-4.
14. Arnold P. Treatment and monitoring of coagulation abnormalities in children undergoing heart surgery. Paediatr Anaesth 2011;21:494-503.
15. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open- heart surgery. Anesth Analg 1999;89:57-64.
16. Manno CS, Hedberg KW, Kim HC, Bunin GR, Nicolson S, Jobes D, Schwartz E, Norwood WI. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children.
Blood 1991;77:930-6.
17. Petaja J, Lundstrom U, Leijala M, Peltola K, Siimes MA. Bleeding and use of blood products after heart operations in infants. J Thorac Cardiovasc Surg 1995;109:524-9.
18. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the full-term infant.
Blood 1987;70:165-72.
19. Eaton MP, Iannoli EM. Coagulation considerations for infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth 2011;21:31-42.
20. Kuhle S, Male C, Mitchell L. Developmental hemostasis: pro- and anticoagulant systems during childhood. Semin Thromb Hemost 2003;29:329- 38.
21. Faraoni D, Van der Linden P. Factors affecting postoperative blood loss in children undergoing cardiac surgery. J Cardiothorac Surg 2014;9:32.
22. Goldschmidt B, Sarkadi B, Gardos G, Matlary A. Platelet producton and survival in cyanotic congenital heart disease. Scand J Haematol 1974;13:110- 5.
23. Gill JC, Wilson AD, Endres-Brooks J, Montgomery RR. Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. Blood 1986;67:758-61.
24. Henriksson P, Varendh G, Lundstrom NR. Haemostatic defects in cyanotic congenital heart disease. Br Heart J 1979;41:23-7.
25. Kontras SB, Sirak HD, Newton WA, Jr. Hematologic abnormalities in children with congenital heart disease. JAMA 1966;195:611-5.
26. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth 2002;16:752-65.
27. Jensen AS, Johansson PI, Bochsen L, Idorn L, Sorensen KE, Thilen U, Nagy E, Furenas E, Sondergaard L. Fibrinogen function is impaired in whole blood
from patients with cyanotic congenital heart disease. Int J Cardiol 2013;167:2210-4
28. Chambers LA, Cohen DM, Davis JT. Transfusion patterns in pediatric open heart surgery. Transfusion 1996;36:150-4.
29. Levy JH. Antifibrinolytic therapy: new data and new concepts. Lancet 2010;376:3-4.
30. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007;356:2301-11.
31. Van Aelbrouck C, Englberger L, Faraoni D. Review of the Fibrinolytic System: Comparison of Different Antifibrinolytics used During Cardiopulmonary Bypass. Recent Pat Cardiovasc Drug Discov 2012;7:175-9.
32. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, Buller HR. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
33. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008;358:2319-31.
34. Mojcik C. Aprotinin and the Systemic Inflammatory Response After Cardiopulmonary Bypass. Ann Thorac Surg 2001;71:745-54.
35. Weber CF, Gorlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, Meininger D. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol 2011;28:57-62.
36. Jimenez JJ, Iribarren JL, Lorente L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Mora ML. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care 2007;11:R117.
37. Koster A, Borgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2013;110:34-40.
38. Faraoni D, Van Aelbrouck C, Cacheux C. Use of tranexamic acid in pediatric cardiac surgery: we really need more. J Anesth 2012;26:301-2.
39. Faraoni D, Cacheux C, Van Aelbrouck C, Ickx BE, Barvais L, Levy JH. Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: A pilot, prospective, randomised, controlled study. Eur J Anaesthesiol 2014;31:491-8.
40. Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, Butterworth J. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass.
Anesthesiology 2002;97:390-9.
41. Fiechtner BK, Nuttall GA, Johnson ME, Dong Y, Sujirattanawimol N, Oliver WC, Jr., Sarpal RS, Oyen LJ, Ereth MH. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg 2001;92:1131- 6.
42. Sharma V, Fan J, Jerath A, Pang KS, Bojko B, Pawliszyn J, Karski JM, Yau T, McCluskey S, Wasowicz M. Pharmacokinetics of tranexamic acid in
patients undergoing cardiac surgery with use of cardiopulmonary bypass.
Anaesthesia 2012;67:1242-50.
43. Cantraine FR, Coussaert EJ. The first object oriented monitor for intravenous anesthesia. J Clin Monit Comput 2000;16:3-10.
44. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 1957;17:237-46.
45. Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose- response relationship of tranexamic acid. Anesthesiology 1995;82:383-92.
46. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013;11:307-14.
47. Bates SM. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 2012;38:673-82.
48. de Moerloose P, Palareti G, Aguilar C, Legnani C, Reber G, Peetz D. A multicenter evaluation of a new quantitative highly sensitive D-dimer assay for exclusion of venous thromboembolism. Thromb Haemost 2008;100:505- 12.
49. Faraoni D, Willems A, Melot C, De Hert S, Van der Linden P. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta- analysis. Eur J Cardiothorac Surg 2012;42:781-6.
50. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900.
51. Chauhan S, Bisoi A, Kumar N, Mittal D, Kale S, Kiran U, Venugopal P. Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2004;12:121-4.
52. Chauhan S, Das SN, Bisoi A, Kale S, Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Surg 2004;18:141-3.
53. Chauhan S, Bisoi A, Modi R, Gharde P, Rajesh MR. Tranexamic acid in paediatric cardiac surgery. Indian J Med Res 2003;118:86-9.
54. Reid RW, Zimmerman AA, Laussen PC, Mayer JE, Gorlin JB, Burrows FA.
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997;84:990-6.
55. Bulutcu FS, Ozbek U, Polat B, Yalcin Y, Karaci AR, Bayindir O. Which may be effective to reduce blood loss after cardiac operations in cyanotic children:
tranexamic acid, aprotinin or a combination? Paediatr Anaesth 2005;15:41-6.
56. Zonis Z, Seear M, Reichert C, Sett S, Allen C. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1996;111:982-7.
57. Levin E, Wu J, Devine DV, Alexander J, Reichart C, Sett S, Seear M.
Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000;83:54-9.
58. Shimizu K, Toda Y, Iwasaki T, Takeuchi M, Morimatsu H, Egi M, Suemori T, Suzuki S, Morita K, Sano S. Effect of tranexamic acid on blood loss in pediatric cardiac surgery: a randomized trial. J Anesth 2011;25:823-30.
59. Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Eur J Cardiothorac Surg 2009;35:167-71.
60. Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G. Tranexamic acid versus varepsilon-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. Eur J Cardiothorac Surg 2011;39:892- 7.
61. Faraoni D. Safety of tranexamic acid in pediatric cardiac surgery: what we do not know. Eur J Cardiothorac Surg 2011;40:1550-1.
62. Koster A, Schirmer U. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era. Current Opin Anaesthesiol 2011;24:92-7.
63. Schouten ES, van de Pol AC, Schouten AN, Turner NM, Jansen NJ, Bollen CW. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis.
Pediatr Crit Care Med 2009;10:182-90.
64. Eaton MP. Antifibrinolytic therapy in surgery for congenital heart disease.
Anesth Analg 2008;106:1087-100.
65. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI.
Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002;123:110-8.
66. Graser TA, Godel HG, Albers S, Foldi P, Furst P. An ultra rapid and sensitive high-performance liquid chromatographic method for determination of tissue and plasma free amino acids. Analytical biochemistry 1985;151:142-52.
67. Goobie SM, Meier PM, Sethna NF, Soriano SG, Zurakowski D, Samant S, Pereira LM. Population pharmacokinetics of tranexamic Acid in paediatric patients undergoing craniosynostosis surgery. Clin Pharmacokinet 2013;52:267-76.
68. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A Practical Tranexamic Acid Dosing Scheme Based on Population Pharmacokinetics in Children Undergoing Cardiac Surgery. Anesthesiology 2013;118:853-62.
69. Andersson L, Nilsoon IM, Colleen S, Granstrand B, Melander B. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Annals of the New York Academy of Sciences 1968;146:642-58.
70. Yee BE, Wissler RN, Zanghi CN, Feng C, Eaton MP. The Effective Concentration of Tranexamic Acid for Inhibition of Fibrinolysis in Neonatal Plasma In Vitro. Anesth Analg 2013;117:767-72.
71. Faraoni D, Goobie SM. New Insights About the Use of Tranexamic Acid in Children Undergoing Cardiac Surgery: From Pharmacokinetics to Pharmacodynamics. Anesth Analg 2013;117:760-2.
72. Faraoni D, Rozen L, Willems A, Sanchez Torres C, Pereira LM, Demulder A, Van der Linden P. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease. Blood Coag Fibrinol 2014 Epub Ahead of Print.
73. Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP. Comparative analysis of
antifibrinolytic medications in pediatric heart surgery. J Thorac Cardiovasc Surg 2012;143:550-7.
74. Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011;113:1003-12.
75. Iqbal A, Morton C, Kong KL. Fibrinolysis during anaphylaxis, and its spontaneous resolution, as demonstrated by thromboelastography. Br J Anaesth 2010;105:168-71.
76. Hunt BJ, Raza I, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients: a reply to a rebuttal. J Thromb Haemost 2013;11:1437-8.
77. Brodsky I, Gill DN, Lusch CJ. Fibrinolysis in congenital heart disease.
Preoperative treatment with epsilon-aminocaproic acid. Am J Clin Pathol 1969;51:51-7.
78. Dennis LH, Stewart JL, Conrad ME. Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease. Lancet 1967;1:1088-9.
79. Spiezia L, Campello E, Simioni P. "Hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts? Int J Cardiol 2013;168:2914.
80. Dirkmann D, Gorlinger K, Peters J. Assessment of Early Thromboelastometric Variables from Extrinsically Activated Assays With and Without Aprotinin for Rapid Detection of Fibrinolysis. Anesth Analg 2014;119:533-42.
81. Dekker SE, Viersen VA, Duvekot A, de Jong M, van den Brom CE, van de Ven PM, Schober P, Boer C. Lysis onset time as diagnostic rotational
thromboelastometry parameter for fast detection of hyperfibrinolysis.
Anesthesiology 2014;121:89-97.
82. Eisses MJ, Chandler WL. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children. J Cardiothorac Vasc Anesth 2008;22:53-9.
83. Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl 1980;14:41-7.
84. Faraoni D, Savan V, Levy JH, Theusinger OM. Goal-directed coagulation management in the perioperative period of cardiac surgery. J Cardiothorac Vasc Anesth 2013;27:1347-54.
85. Stensballe J, Ostrowski SR, Johansson PI. Viscoelastic guidance of resuscitation. Curr Opin Anaesthesiol 2014;27:212-8.
86. de Lange NM, Lance MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv 2012;67:426-35.
87. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CA, De Robertis E, Filipescu DC, Fries D, Gorlinger K, Haas T, Imberger G, Jacob M, Lance M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, Van der Linden P, Wikkelso AJ, Wouters P, Wyffels P.
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013;30:270-382.
88. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding and
coagulopathy following major trauma: an updated European guideline. Crit Care 2013;17:R76.
89. Lee GC, Kicza AM, Liu KY, Nyman CB, Kaufman RM, Body SC. Does rotational thromboelastometry (ROTEM) improve prediction of bleeding after cardiac surgery? Anesth Analg 2012;115:499-506.
90. Görlinger K, Jambor C, Hanke AA, Dirkmann D, Adamzik M, Hartmann M, Rahe-Meyer N. Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis. Transfus Med Hemother 2007;34:396-411.
91. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, Jakob H, Peters J. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single- center cohort study. Anesthesiology 2011;115:1179-91.
92. Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A, Cohn LH, Zacharowski K. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients.
Anesthesiology 2012;117:531-47.
93. Oswald E, Stalzer B, Heitz E, Weiss M, Schmugge M, Strasak A, Innerhofer P, Haas T. Thromboelastometry (ROTEM) in children: age-related reference ranges and correlations with standard coagulation tests. Br J Anaesth 2010;105:827-35.
94. Osthaus WA, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, Suempelmann R. Whole blood coagulation measured by
modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. Blood Coagul Fibrinolysis 2008;19:220-5.
95. Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery: A retrospective review. Eur J Anaesthesiol 2014;31:317-26.
96. Haas T, Spielmann N, Mauch J, Madjdpour C, Speer O, Schmugge M, Weiss M. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012;108:36-41.
97. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, Saggau W.
Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93:1101-7.
98. Hayashi T, Sakurai Y, Fukuda K, Yada K, Ogiwara K, Matsumoto T, Yoshizawa H, Takahashi Y, Yoshikawa Y, Hayata Y, Taniguchi S, Shima M.
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery. Paediatr Anaesth 2011;21:865-71.
99. Ranucci M. Fibrinogen supplementation in cardiac surgery: where are we now and where are we going? J Cardiothorac Vasc Anesth 2013;27:1-4.
100. Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004;125:69-73.
101. Rahe-Meyer N, Pichlmaier M, Haverich A, Solomon C, Winterhalter M, Piepenbrock S, Tanaka KA. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth 2009;102:785-92.
102. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sorensen B, Hagl C, Pichlmaier M. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013;118:40-50.
103. Solomon C, Cadamuro J, Ziegler B, Schochl H, Varvenne M, Sorensen B, Hochleitner G, Rahe-Meyer N. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients.
Transfusion 2011;51:1695-706.
104. Faraoni D, Willems A, Romlin BS, Belisle S, Van der Linden P. Development of a specific algorithm to guide haemostatic therapy in children undergoing cardiac surgery: A single-centre retrospective study. Eur J Anaesthesiol 2014 Epub Ahead of Print.
105. Ickx BE, Faraoni D. Management of the clotting system: a European perspective. Current Opin Anaesthesiol 2012;25:80-5.
106. Romlin BS, Wahlander H, Berggren H, Synnergren M, Baghaei F, Nilsson K, Jeppsson A. Intraoperative thromboelastometry is associated with reduced transfusion prevalence in pediatric cardiac surgery. Anesth Analg 2011;112:30-6.
107. Savan V, Willems A, Faraoni D, Van der Linden P. A multivariate model for predicting postoperative blood loss in children undergoing cardiac surgery: a preliminary study. Br J Anaesth 2014;112:708-14.
108. Apfel CC, Greim CA, Haubitz I, Goepfert C, Usadel J, Sefrin P, Roewer N. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand 1998;42:495-501.
109. Miller BE, Guzzetta NA, Tosone SR, Levy JH. Rapid evaluation of coagulopathies after cardiopulmonary bypass in children using modified thromboelastography. Anesth Analg 2000;90:1324-30.
110. Tirosh-Wagner T, Strauss T, Rubinshtein M, Tamarin I, Mishaly D, Paret G, Kenet G. Point of care testing in children undergoing cardiopulmonary bypass.
Pediatric blood & cancer 2011;56:794-8.
111. Karam O, Lacroix J, Robitaille N, Rimensberger PC, Tucci M. Association between plasma transfusions and clinical outcome in critically ill children: a prospective observational study. Vox sanguinis 2013;104:342-9.
112. Faraoni D, Hardy JF, Van der Linden P. An early, multimodal, goal-directed approach of coagulopathy in the bleeding traumatized patient. Curr Opin Anaesthesiol 2013;26:193-5.
113. Hofer A, Kozek-Langenecker S, Schaden E, Panholzer M, Gombotz H. Point- of-care assessment of platelet aggregation in paediatric open heart surgery. Br J Anaesth 2011;107:587-92.
114. Ranucci M, Di Dedda U, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G, Surgical, Clinical Outcome Research G. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. Ann Thorac Surg 2012;94:1134-41.
115. Koster A, Faraoni D, Levy JH. Antifibrinolytic Therapy for Cardiac Surgery:
An Update. Anesthesiology 2015 Epub Ahead of Print.
116. Faraoni D, Van Der Linden P. A systematic review of antifibrinolytics and massive injury. Minerva Anestesiol 2014;80:1115-22.
117. Faraoni D, Carlier C, Samama CM, Levy JH, Ducloy-Bouthors AS. [Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: A systematic review with meta- analysis]. Ann Fr Anesth Reanim 2014;33:563-71.
118. Faraoni D, Fenger-Eriksen C, Gillard S, Willems A, Levy JH, Van der Linden P. Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study. Pediatr Anesth 2015 Epub Ahead of Print.
119. Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br J Anaesth 2015;114:91-102.
